FDA adviser who resigned over Alzheimer’s drug says ‘no good proof’ it really works

One of many FDA advisory panel members who resigned after the company granted Biogen’s Alzheimer’s drug Accelerated Approval has mentioned “the drug confirmed no good proof that it labored.”

Leave a Reply

Your email address will not be published. Required fields are marked *